Clay Capital — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
A bio-pharmaceutical and real estate holding company that conducts cannabis genomic research through its subsidiaries to develop improved cannabis and hemp strains for medical and industrial applications, while maintaining agricultural licenses and significant real estate holdings.
Tucson, US
Glenn E Martin(Director and Chief Executive Officer)Nicole M Breen(Director, Secretary and Treasurer)inPatrick E Williams(Director)
Co-investorsFulcrum Global Capital
Infinite Roots cultivates mycelium (mushroom roots) via liquid fermentation using natural side streams such as brewers' spent grain, turning it into protein-, fiber-, and vitamin-rich culinary ingredients.
BiotechCircular EconomyClimate TechFoodTechHamburg, DE
Mazen
Co-investorsFoodLabsJoyance PartnersSimon CapitalUnruly CapitalHappiness Capitalredalpine
WeedOUT develops a biological herbicide using proprietary sterile weed pollen to control resistant weeds in agriculture.
AgTechBiotech
Efrat Lidor Nili(Founder)in
Co-investorsFulcrum Global CapitalRadicle GrowthZORA
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.